Curi RMB Capital’s West Pharmaceutical WST Stock Holding History

Curi RMB Capital’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.2M	Buy	75,808 +3,642	+5%	+$1.11M	0.42%	64
2026 Q1	$18.1M	Sell	72,166 -367	-0.5%	-$91.3K	0.32%	82
2025 Q4	$20M	Sell	72,533 -1,960	-3%	-$536K	0.35%	71
2025 Q3	$19.5M	Sell	74,493 -2,232	-3%	-$542K	0.36%	71
2025 Q2	$16.8M	Buy	76,725 +3,574	+5%	+$764K	0.32%	84
2025 Q1	$16.4M	Buy	73,151 +408	+0.6%	+$112K	0.4%	73
2024 Q4	$23.8M	Buy	72,743 +93	+0.1%	+$29.3K	0.55%	39
2024 Q3	$21.8M	Buy	72,650 +2,614	+4%	+$801K	0.5%	57
2024 Q2	$23.1M	Buy	70,036 +326	+0.5%	+$115K	0.55%	45
2024 Q1	$27.6M	Buy	69,710 +3,708	+6%	+$1.37M	0.63%	41
2023 Q4	$23.2M	Sell	66,002 -1,419	-2%	-$502K	0.71%	37
2023 Q3	$25.3M	Buy	67,421 +2,397	+4%	+$927K	0.87%	27
2023 Q2	$24.9M	Buy	65,024 +181	+0.3%	+$64.7K	0.82%	31
2023 Q1	$22.5M	Buy	64,843 +2,687	+4%	+$785K	0.78%	34
2022 Q4	$14.6M	Sell	62,156 -7,599	-11%	-$1.8M	0.52%	62
2022 Q3	$17.2M	Buy	69,755 +188	+0.3%	+$57.3K	0.64%	49
2022 Q2	$21M	Buy	69,567 +35	+0.1%	+$11.4K	0.72%	44
2022 Q1	$28.6M	Buy	69,532 +1,728	+3%	+$676K	0.9%	34
2021 Q4	$31.8M	Sell	67,804 -724	-1%	-$312K	0.96%	30
2021 Q3	$29.1M	Sell	68,528 -1,789	-3%	-$754K	0.96%	28
2021 Q2	$25.3M	Buy	70,317 +1,810	+3%	+$598K	0.84%	33
2021 Q1	$19.3M	Buy	68,507 +2,924	+4%	+$837K	0.71%	40
2020 Q4	$18.6M	Sell	65,583 -6,472	-9%	-$1.82M	0.68%	38
2020 Q3	$19.8M	Sell	72,055 -5,256	-7%	-$1.39M	0.86%	30
2020 Q2	$17.6M	Sell	77,311 -24,114	-24%	-$4.74M	0.77%	32
2020 Q1	$15.4M	Buy	101,425 +15,414	+18%	+$2.37M	0.73%	33
2019 Q4	$12.9M	Sell	86,011 -16,827	-16%	-$2.45M	0.36%	76
2019 Q3	$14.6M	Buy	102,838 +3,303	+3%	+$455K	0.38%	67
2019 Q2	$12.5M	Buy	99,535 +538	+0.5%	+$63.5K	0.32%	93
2019 Q1	$10.9M	Buy	98,997 +17,367	+21%	+$1.81M	0.28%	101
2018 Q4	$8M	Buy	81,630 +6,526	+9%	+$708K	0.2%	127
2018 Q3	$9.27M	Sell	75,104 -5,784	-7%	-$649K	0.22%	131
2018 Q2	$8.03M	Sell	80,888 -38,996	-33%	-$3.59M	0.19%	148
2018 Q1	$10.6M	Sell	119,884 -10,166	-8%	-$951K	0.27%	105
2017 Q4	$12.8M	Sell	130,050 -8,937	-6%	-$876K	0.33%	78
2017 Q3	$13.4M	Sell	138,987 -33,176	-19%	-$3M	0.35%	84
2017 Q2	$16.3M	Buy	+172,163	New	+$15.8M	0.47%	44
2016 Q4	–	Sell	-164,858	Closed	-$12.3M	–	565
2016 Q3	$12.3M	Sell	164,858 -4,148	-2%	-$329K	0.67%	44
2016 Q2	$12.8M	Sell	169,006 -98,488	-37%	-$7.17M	0.67%	39
2016 Q1	$18.5M	Sell	267,494 -78,055	-23%	-$4.7M	1.21%	20
2015 Q4	$20.8M	Sell	345,549 -7,736	-2%	-$465K	0.96%	9
2015 Q3	$19.1M	Sell	353,285 -18,951	-5%	-$1.1M	1.27%	14
2015 Q2	$21.6M	Sell	372,236 -17,057	-4%	-$952K	1.41%	12
2015 Q1	$23.4M	Sell	389,293 -7,911	-2%	-$422K	1.41%	9
2014 Q4	$21.1M	Buy	397,204 +187,938	+90%	+$9.4M	1.29%	14
2014 Q3	$9.37M	Buy	+209,266	New	+$8.89M	0.57%	47

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Curi RMB Capital's WST Position: Q2 2026 in Review

Curi RMB Capital increased its West Pharmaceutical (WST) stake by 5% in Q2 2026, buying an estimated $1.11M and bringing the position to 75,808 shares worth $27.2M. The position accounts for 0.42% of the portfolio, ranked #64.

Curi RMB Capital first reported a position in WST in Q3 2014 and has held it in 46 quarters since. The position peaked at $31.8M in Q4 2021. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Curi RMB Capital held 75,808 shares of West Pharmaceutical worth $27.2M as of Q2 2026.
Curi RMB Capital bought 3,642 West Pharmaceutical shares in Q2 2026, an estimated $1.11M.
West Pharmaceutical made up 0.42% of Curi RMB Capital's portfolio in Q2 2026, its #64 holding.
Curi RMB Capital first reported a position in West Pharmaceutical in Q3 2014 and has held it in 46 quarters since.
Curi RMB Capital's West Pharmaceutical position peaked at $31.8M in Q4 2021.
830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Curi RMB Capital's 13F filing for Q2 2026, filed 14 Aug 2026.